I.Q. Meditech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 12-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 7.60 Cr
as on 12-12-2024
- Revenue -23.06%
(FY 2021)
- Profit -80.18%
(FY 2021)
- Ebitda -24.98%
(FY 2021)
- Net Worth 1.48%
(FY 2021)
- Total Assets -8.55%
(FY 2021)
About I.Q. Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹7.60 Cr.
Faiz Iqbal, Shan Iqbal, Rakesh Yadav, and One other member serve as directors at the Company.
- CIN/LLPIN
U33111UP2013PTC058796
- Company No.
058796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- LocationSambhal, Uttar Pradesh
- Telephone
- Email Address
- Website
- Social Media-
What products or services does I.Q. Meditech Private Limited offer?
I.Q. Meditech Private Limited offers a wide range of products and services, including Medical Tubes, Scalp Vein Sets, Infusion Syringes & Supplies, Scalpels, Needles & Scissors, Surgical Needles, Syringes, Syringe Needles, Hypodermic Needles.
Who are the key members and board of directors at I.Q. Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Faiz Iqbal  | Director | 02-Aug-2013 | Current |
| Shan Iqbal | Director | 02-Aug-2013 | Current |
| Rakesh Yadav | Director | 15-Jan-2015 | Current |
| Shuail Iqbal | Director | 15-Jan-2015 | Current |
Financial Performance of I.Q. Meditech.
I.Q. Meditech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.06% decrease. The company also saw a substantial fall in profitability, with a 80.18% decrease in profit. The company's net worth moved up by a moderate rise of 1.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of I.Q. Meditech?
In 2021, I.Q. Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
I.Q. Fashion Textile Private LimitedActive 5 months 15 daysFaiz Iqbal, Shan Iqbal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Jul 2022 | ₹1.70 Cr | Open |
Prathama Bank Creation Date: 29 Mar 2014 | ₹5.90 Cr | Open |
How Many Employees Work at I.Q. Meditech?
Unlock and access historical data on people associated with I.Q. Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of I.Q. Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I.Q. Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
